Edition:
United States

ALK Abello A/S (ALKb.CO)

ALKb.CO on Copenhagen Stock Exchange

852.00DKK
1 Dec 2016
Change (% chg)

kr.-11.00 (-1.27%)
Prev Close
kr.863.00
Open
kr.846.00
Day's High
kr.855.00
Day's Low
kr.846.00
Volume
7,303
Avg. Vol
16,912
52-wk High
kr.1,300.00
52-wk Low
kr.785.00

ALKb.CO

Chart for ALKb.CO

About

ALK Abello A/S is a Denmark-based company active within the pharmaceutical industry. It is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The... (more)

Overall

Beta: 0.52
Market Cap(Mil.): kr.8,378.92
Shares Outstanding(Mil.): 9.21
Dividend: 5.00
Yield (%): 0.55

Financials

  ALKb.CO Industry Sector
P/E (TTM): 24.56 29.13 29.87
EPS (TTM): 37.05 -- --
ROI: 10.77 15.56 14.95
ROE: 13.86 16.69 16.29

BRIEF-Alk Abello Q3 EBIT ex-items down at DKK 80 million, upgrades guidance

* Q3 total revenue 630 million Danish crowns ($93 million)versus 667 million crowns year ago

Nov 10 2016

BRIEF-Alk Abello Q2 EBIT DKK 119 million, beats expectations

* Q2 total revenue 773 million Danish crowns ($116.5 million)(Reuters poll 688 million crowns)

Aug 16 2016

BRIEF-Merck plans to end partnership agreement with Alk Abello

* Said on Tuesday MSD (known as Merck in the United States and Canada) had informed ALK of its plans to end their partnership agreement

Jul 27 2016

Earnings vs. Estimates